{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:19:33Z","timestamp":1790558373844,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>N<\/jats:italic>\n                    -[2-(5-methoxy-1\n                    <jats:italic>H<\/jats:italic>\n                    -indol-3-yl) ethyl] or simply melatonin is a biogenic amine produced by pineal gland and recently recognized various other organs. Because of a broad range of biological function melatonin is considered as a therapeutic agent with high efficacy in the treatment of multiple disorders, such as cancer, degenerative disorders and immune disease. However, since melatonin can affect receptors on the cellular membrane, in the nucleus and can act as an anti-oxidant molecule, some unwanted effects may be observed after administration. Therefore, the entrapment of melatonin in biocompatible, biodegradable and safe nano-delivery systems can prevent its degradation in circulation; decrease its toxicity with increased half-life, enhanced pharmacokinetic profile leading to improved patient compliance. Because of this, nanoparticles have been used to deliver melatonin in multiple studies, and the present article aims to cumulatively illustrate their findings.\n                  <\/jats:p>","DOI":"10.1186\/s12935-022-02472-7","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T06:03:39Z","timestamp":1643436219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Nanotechnology-based advances in the efficient delivery of melatonin"],"prefix":"10.1186","volume":"22","author":[{"given":"Mohammad","family":"Mirza-Aghazadeh-Attari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainaz","family":"Mihanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahman","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9776-5816","authenticated-orcid":false,"given":"Maryam","family":"Majidinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"issue":"Pt 3","key":"2472_CR1","first-page":"517","volume":"189","author":"J Fell","year":"1996","unstructured":"Fell J. Targeting of drugs and delivery systems to specific sites in the gastrointestinal tract. J Anat. 1996;189(Pt 3):517.","journal-title":"J Anat"},{"issue":"29","key":"2472_CR2","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.2174\/1381612821666150901103208","volume":"21","author":"K Jain","year":"2015","unstructured":"Jain K, KumarMehra N, Jain KN. Nanotechnology in drug delivery: safety and toxicity issues. Curr Pharmaceut Design. 2015;21(29):4252\u201361.","journal-title":"Curr Pharmaceut Design."},{"issue":"3","key":"2472_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1517\/17425255.2015.992781","volume":"11","author":"F Ara\u00fajo","year":"2015","unstructured":"Ara\u00fajo F, Shrestha N, Granja PL, Hirvonen J, Santos HA, Sarmento B. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers. Expert Opin Drug Metab Toxicol. 2015;11(3):381\u201393.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"11","key":"2472_CR4","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/pharmaceutics12111022","volume":"12","author":"P Lara","year":"2020","unstructured":"Lara P, Chan AB, Cruz LJ, Quest AF, Kogan MJ. Exploiting the natural properties of extracellular vesicles in targeted delivery towards specific cells and tissues. Pharmaceutics. 2020;12(11):1022.","journal-title":"Pharmaceutics"},{"issue":"9","key":"2472_CR5","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/molecules25092193","volume":"25","author":"AA Yetisgin","year":"2020","unstructured":"Yetisgin AA, Cetinel S, Zuvin M, Kosar A, Kutlu O. Therapeutic nanoparticles and their targeted delivery applications. Molecules. 2020;25(9):2193.","journal-title":"Molecules"},{"issue":"2","key":"2472_CR6","doi-asserted-by":"publisher","first-page":"e12702","DOI":"10.1111\/jpi.12702","volume":"70","author":"JA Boutin","year":"2021","unstructured":"Boutin JA, Jockers R. Melatonin controversies, an update. J Pineal Res. 2021;70(2):e12702.","journal-title":"J Pineal Res"},{"key":"2472_CR7","first-page":"05","volume":"15","author":"J Lawrence","year":"2018","unstructured":"Lawrence J. Making drugs work better: four new drug delivery methods. Lung Cancer. 2018;15:05.","journal-title":"Lung Cancer"},{"issue":"49","key":"2472_CR8","doi-asserted-by":"publisher","first-page":"15386","DOI":"10.1021\/la402493q","volume":"29","author":"MW Ambrogio","year":"2013","unstructured":"Ambrogio MW, Frasconi M, Yilmaz MD, Chen X. New methods for improved characterization of silica nanoparticle-based drug delivery systems. Langmuir. 2013;29(49):15386\u201393.","journal-title":"Langmuir"},{"issue":"5","key":"2472_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/sj.bjp.0707130","volume":"150","author":"C Medina","year":"2007","unstructured":"Medina C, Santos-Martinez M, Radomski A, Corrigan O, Radomski M. Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol. 2007;150(5):552\u20138.","journal-title":"Br J Pharmacol"},{"issue":"12","key":"2472_CR10","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1164\/rccm.200504-613PP","volume":"172","author":"S Gelperina","year":"2005","unstructured":"Gelperina S, Kisich K, Iseman MD, Heifets L. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med. 2005;172(12):1487\u201390.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"2472_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/nmat3788","volume":"12","author":"JA Hubbell","year":"2013","unstructured":"Hubbell JA, Langer R. Translating materials design to the clinic. Nat Mater. 2013;12(11):963.","journal-title":"Nat Mater"},{"issue":"8","key":"2472_CR12","doi-asserted-by":"publisher","first-page":"0063","DOI":"10.1038\/s41570-017-0063","volume":"1","author":"A Kakkar","year":"2017","unstructured":"Kakkar A, Traverso G, Farokhzad OC, Weissleder R, Langer R. Evolution of macromolecular complexity in drug delivery systems. Nat Rev Chem. 2017;1(8):0063.","journal-title":"Nat Rev Chem"},{"issue":"9","key":"2472_CR13","doi-asserted-by":"publisher","first-page":"8655","DOI":"10.1021\/acsnano.5b03184","volume":"9","author":"S Zhang","year":"2015","unstructured":"Zhang S, Gao H, Bao G. Physical principles of nanoparticle cellular endocytosis. ACS Nano. 2015;9(9):8655\u201371.","journal-title":"ACS Nano"},{"key":"2472_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jconrel.2014.03.053","volume":"190","author":"AC Anselmo","year":"2014","unstructured":"Anselmo AC, Mitragotri S. An overview of clinical and commercial impact of drug delivery systems. J Contr Rel. 2014;190:15\u201328.","journal-title":"J Contr Rel"},{"key":"2472_CR15","doi-asserted-by":"crossref","unstructured":"Usta A, Asmatulu R. Synthesis and analysis of electrically sensitive hydrogels incorporated with cancer drugs. J Pharm Drug Deliv Res. 5. 2016;5(2).","DOI":"10.4172\/2325-9604.1000146"},{"issue":"12","key":"2472_CR16","first-page":"1541","volume":"16","author":"B Yousefi","year":"2016","unstructured":"Yousefi B, Zarghami N, Samadi N, Majidinia M. Peroxisome proliferator-activated receptors and their ligands in cancer drug-resistance: opportunity or challenge. Anti-Cancer Agents Med Chem Formerly Curr Med Chem Anti-Cancer Agents. 2016;16(12):1541\u20138.","journal-title":"Anti-Cancer Agents Med Chem Formerly Curr Med Chem Anti-Cancer Agents."},{"issue":"5","key":"2472_CR17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/iub.2215","volume":"72","author":"M Majidinia","year":"2020","unstructured":"Majidinia M, Mirza-Aghazadeh-Attari M, Rahimi M, Mihanfar A, Karimian A, Safa A, et al. Overcoming multidrug resistance in cancer: recent progress in nanotechnology and new horizons. IUBMB Life. 2020;72(5):855\u201371.","journal-title":"IUBMB Life"},{"issue":"8","key":"2472_CR18","first-page":"118","volume":"61","author":"B Yousefi","year":"2015","unstructured":"Yousefi B, Samadi N, Baradaran B, Rameshknia V, Shafiei-Irannejad V, Majidinia M, et al. Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562\/DOX) cells. Cell Mol Biol (Noisy-le-grand). 2015;61(8):118\u201322.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"10","key":"2472_CR19","doi-asserted-by":"publisher","first-page":"101042831771650","DOI":"10.1177\/1010428317716501","volume":"39","author":"B Yousefi","year":"2017","unstructured":"Yousefi B, Azimi A, Majidinia M, Shafiei-Irannejad V, Badalzadeh R, Baradaran B, et al. Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPAR\u03b3-dependent manner in leukemia cells. Tumor Biol. 2017;39(10):1010428317716501.","journal-title":"Tumor Biol"},{"key":"2472_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.addr.2018.07.013","volume":"132","author":"W Zhan","year":"2018","unstructured":"Zhan W, Alamer M, Xu XY. Computational modelling of drug delivery to solid tumour: understanding the interplay between chemotherapeutics and biological system for optimised delivery system. Adv Drug Deliv Rev. 2018;132:81\u2013103.","journal-title":"Adv Drug Deliv Rev"},{"key":"2472_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4172\/2325-9604.1000138","volume":"4","author":"R Joshi","year":"2015","unstructured":"Joshi R, Devarajan P. Anionic self micro-emulsifying drug delivery system (SMEDDS) of docetaxel for circulation longevity. J Pharm Drug Deliv Res. 2015;4:3.","journal-title":"J Pharm Drug Deliv Res"},{"key":"2472_CR22","doi-asserted-by":"crossref","unstructured":"Mahipalreddy D, Narendar D, Devendhar K, Dinesh S, Kiran S, Nagaraj B. Preparation and evaluation of ketoprofen enteric coated mini tablets for prevention of chronic inflammatory disease. J Pharm Drug Deliv Res. 2016;04.","DOI":"10.4172\/2325-9604.1000135"},{"key":"2472_CR23","unstructured":"Nair AK, Rao VB, Mallu UR, Ramana V, Reddy BH. Development and comparative assessment of hydrocolloid based against wax based gastro retentive bilayered floating tablet designs of atorvastatin calcium using Qbd approach. J Pharm Drug Deliv Res. 2016;4(3)"},{"key":"2472_CR24","doi-asserted-by":"crossref","unstructured":"Koteswari P, Brahmani S, Srinivasababu P, Pinnamraju D, Murthy V. Fabrication of a novel device containing famotidine for gastro retentive delivery using carbohydrate polymers. J Pharm Drug Deliv Res 2015;4(2).","DOI":"10.4172\/2325-9604.1000130"},{"key":"2472_CR25","first-page":"2","volume":"3","author":"K Brijesh","year":"2015","unstructured":"Brijesh K. Physicochemical characterization and in-vitro dissolution enhancement of bicalutamide-Hp-\u0392-Cd complex. J Pharm Drug Deliv Res. 2015;3:2.","journal-title":"J Pharm Drug Deliv Res"},{"key":"2472_CR26","first-page":"2","volume":"3","author":"C Ranjna","year":"2014","unstructured":"Ranjna C. Inhibiting human lactate dehydrogenase-C for male fertility control; initial hits. J Pharm Drug Deliv Res. 2014;3:2.","journal-title":"J Pharm Drug Deliv Res"},{"issue":"2","key":"2472_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/jpi.12026","volume":"54","author":"DX Tan","year":"2013","unstructured":"Tan DX, Manchester LC, Liu X, Rosales-Corral SA, Acuna-Castroviejo D, Reiter RJ. Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin\u2019s primary function and evolution in eukaryotes. J Pineal Res. 2013;54(2):127\u201338.","journal-title":"J Pineal Res"},{"issue":"22","key":"2472_CR28","doi-asserted-by":"publisher","first-page":"12418","DOI":"10.1073\/pnas.96.22.12418","volume":"96","author":"EM Khalil","year":"1999","unstructured":"Khalil EM, De Angelis J, Ishii M, Cole PA. Mechanism-based inhibition of the melatonin rhythm enzyme: pharmacologic exploitation of active site functional plasticity. Proc Natl Acad Sci. 1999;96(22):12418\u201323.","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"2472_CR29","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00228-015-1873-4","volume":"71","author":"NG Harps\u00f8e","year":"2015","unstructured":"Harps\u00f8e NG, Andersen LPH, G\u00f6genur I, Rosenberg J. Clinical pharmacokinetics of melatonin: a systematic review. Eur J Clin Pharmacol. 2015;71(8):901\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1\u20132","key":"2472_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijpharm.2009.05.024","volume":"378","author":"HTT Tran","year":"2009","unstructured":"Tran HTT, Tran PHL, Lee B-J. New findings on melatonin absorption and alterations by pharmaceutical excipients using the using chamber technique with mounted rat gastrointestinal segments. Int J Pharm. 2009;378(1\u20132):9\u201316.","journal-title":"Int J Pharm"},{"issue":"3","key":"2472_CR31","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3390\/nu7031494","volume":"7","author":"R Stoffaneller","year":"2015","unstructured":"Stoffaneller R, Morse N. A review of dietary selenium intake and selenium status in Europe and the Middle East. Nutrients. 2015;7(3):1494\u2013537.","journal-title":"Nutrients"},{"key":"2472_CR32","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2147\/IJN.S157541","volume":"13","author":"B Hosnedlova","year":"2018","unstructured":"Hosnedlova B, Kepinska M, Skalickova S, Fernandez C, Ruttkay-Nedecky B, Peng Q, et al. Nano-selenium and its nanomedicine applications: a critical review. Int J Nanomed. 2018;13:2107.","journal-title":"Int J Nanomed"},{"key":"2472_CR33","first-page":"1","volume-title":"Selenium nanoparticles and their applications. Encyclopedia of Nanoscience and Nanotehnology","author":"S Chhabria","year":"2016","unstructured":"Chhabria S, Desai K. Selenium nanoparticles and their applications. Encyclopedia of Nanoscience and Nanotehnology. USA: American Scientific Publishers; 2016. p. 1\u201332."},{"key":"2472_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejpb.2017.10.010","volume":"122","author":"Q Xie","year":"2018","unstructured":"Xie Q, Deng W, Yuan X, Wang H, Ma Z, Wu B, et al. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect. Eur J Pharm Biopharm. 2018;122:87\u201395.","journal-title":"Eur J Pharm Biopharm"},{"key":"2472_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.colsurfb.2018.06.006","volume":"170","author":"S Menon","year":"2018","unstructured":"Menon S, ShrudhiDevi KS, Santhiya R, Rajeshkumar S, Kumar V. Selenium nanoparticles: a potent chemotherapeutic agent and an elucidation of its mechanism. Colloids Surfaces B Biointerfaces. 2018;170:280.","journal-title":"Colloids Surfaces B Biointerfaces."},{"issue":"6","key":"2472_CR36","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/j.1745-7254.2005.00745.x","volume":"26","author":"H Wang","year":"2005","unstructured":"Wang H, Wei W, Zhang SY, Shen YX, Wang NP, Yue L, et al. Melatonin-selenium nanoparticles protects liver against immunological injury induced by bacillus Calmette-Gu\u00e9rin and lipopolysaccharide 1. Acta Pharmacol Sin. 2005;26(6):745\u201352.","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"2472_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1600-079X.2005.00231.x","volume":"39","author":"H Wang","year":"2005","unstructured":"Wang H, Wei W, Zhang SY, Shen YX, Yue L, Wang NP, et al. Melatonin-selenium nanoparticles inhibit oxidative stress and protect against hepatic injury induced by Bacillus Calmette\u2013Gu\u00e9rin\/lipopolysaccharide in mice. J Pineal Res. 2005;39(2):156\u201363.","journal-title":"J Pineal Res"},{"key":"2472_CR38","first-page":"1","volume-title":"Chitosan based biomaterials","author":"T Aminabhavi","year":"2017","unstructured":"Aminabhavi T, Dharupaneedi S, More U. The role of nanotechnology and chitosan-based biomaterials for tissue engineering and therapeutic delivery. In: Chitosan based biomaterials, vol. 2. Netherlands: Elsevier; 2017. p. 1\u201329."},{"issue":"4","key":"2472_CR39","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.eurpolymj.2012.12.009","volume":"49","author":"F Croisier","year":"2013","unstructured":"Croisier F, J\u00e9r\u00f4me C. Chitosan-based biomaterials for tissue engineering. Eur Polym J. 2013;49(4):780\u201392.","journal-title":"Eur Polym J"},{"issue":"8","key":"2472_CR40","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3109\/02652048.2011.622053","volume":"28","author":"A Hafner","year":"2011","unstructured":"Hafner A, Lovri\u0107 J, Pepi\u0107 I, Filipovi\u0107-Gr\u010di\u0107 J. Lecithin\/chitosan nanoparticles for transdermal delivery of melatonin. J Microencapsul. 2011;28(8):807\u201315.","journal-title":"J Microencapsul"},{"issue":"9","key":"2472_CR41","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1248\/cpb.59.1117","volume":"59","author":"A Hafner","year":"2011","unstructured":"Hafner A, D\u00fcrrigl M, Pepi\u0107 I, Filipovi\u0107-Gr\u010di\u0107 J. Short-and long-term stability of lyophilised melatonin-loaded lecithin\/chitosan nanoparticles. Chem Pharm Bull. 2011;59(9):1117\u201323.","journal-title":"Chem Pharm Bull"},{"issue":"1\u20132","key":"2472_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000489667","volume":"102","author":"M Shokrzadeh","year":"2018","unstructured":"Shokrzadeh M, Ghassemi-Barghi N. Melatonin loading chitosan-tripolyphosphate nanoparticles: application in attenuating etoposide-induced genotoxicity in HepG2 cells. Pharmacology. 2018;102(1\u20132):74\u201380.","journal-title":"Pharmacology"},{"issue":"2","key":"2472_CR43","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.ijpharm.2015.11.028","volume":"496","author":"B Topal","year":"2015","unstructured":"Topal B, Alt\u0131ndal D\u00c7, G\u00fcm\u00fc\u015fderelio\u011flu M. Melatonin\/HP\u03b2CD complex: Microwave synthesis, integration with chitosan scaffolds and inhibitory effects on MG-63CELLS. Int J Pharm. 2015;496(2):801\u201311.","journal-title":"Int J Pharm"},{"issue":"36","key":"2472_CR44","doi-asserted-by":"publisher","first-page":"365102","DOI":"10.1088\/1361-6528\/aa7c76","volume":"28","author":"SK Yadav","year":"2017","unstructured":"Yadav SK, Srivastava AK, Dev A, Kaundal B, Choudhury SR, Karmakar S. Nanomelatonin triggers superior anticancer functionality in a human malignant glioblastoma cell line. Nanotechnology. 2017;28(36):365102.","journal-title":"Nanotechnology"},{"issue":"2","key":"2472_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ijpharm.2009.07.001","volume":"381","author":"A Hafner","year":"2009","unstructured":"Hafner A, Lovri\u0107 J, Voinovich D, Filipovi\u0107-Gr\u010di\u0107 J. Melatonin-loaded lecithin\/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers. Int J Pharm. 2009;381(2):205\u201313.","journal-title":"Int J Pharm"},{"issue":"1","key":"2472_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0378-5173(03)00149-2","volume":"260","author":"I El-Gibaly","year":"2003","unstructured":"El-Gibaly I, Meki A, Abdel-Ghaffar S. Novel B melatonin-loaded chitosan microcapsules: in vitro characterization and antiapoptosis efficacy for aflatoxin B1-induced apoptosis in rat liver. Int J Pharm. 2003;260(1):5\u201322.","journal-title":"Int J Pharm"},{"key":"2472_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.carbpol.2016.03.074","volume":"146","author":"F Bla\u017eevi\u0107","year":"2016","unstructured":"Bla\u017eevi\u0107 F, Mileki\u0107 T, Romi\u0107 MD, Jureti\u0107 M, Pepi\u0107 I, Filipovi\u0107-Gr\u010di\u0107 J, et al. Nanoparticle-mediated interplay of chitosan and melatonin for improved wound epithelialisation. Carbohyd Polym. 2016;146:445\u201354.","journal-title":"Carbohyd Polym"},{"key":"2472_CR48","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejps.2015.04.003","volume":"75","author":"A Hafner","year":"2015","unstructured":"Hafner A, Lovri\u0107 J, Romi\u0107 MD, Jureti\u0107 M, Pepi\u0107 I, Cetina-\u010ci\u017emek B, et al. Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model. Eur J Pharm Sci. 2015;75:142\u201350.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"2472_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1600-079X.2008.00651.x","volume":"46","author":"R Rezzani","year":"2009","unstructured":"Rezzani R, Rodella LF, Fraschini F, Gasco MR, Demartini G, Musicanti C, et al. Melatonin delivery in solid lipid nanoparticles: prevention of cyclosporine A induced cardiac damage. J Pineal Res. 2009;46(3):255\u201361.","journal-title":"J Pineal Res"},{"issue":"4","key":"2472_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4103\/0250-474X.57282","volume":"71","author":"S Mukherjee","year":"2009","unstructured":"Mukherjee S, Ray S, Thakur R. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2009;71(4):349.","journal-title":"Indian J Pharm Sci"},{"issue":"10","key":"2472_CR51","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1166\/jnn.2007.809","volume":"7","author":"L Priano","year":"2007","unstructured":"Priano L, Esposti D, Esposti R, Castagna G, De Medici C, Fraschini F, et al. Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems. J Nanosci Nanotechnol. 2007;7(10):3596\u2013601.","journal-title":"J Nanosci Nanotechnol"},{"issue":"4","key":"2472_CR52","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1034\/j.1600-079X.2001.310403.x","volume":"31","author":"MF Xu","year":"2001","unstructured":"Xu MF, Ho S, Qian ZM, Tang PL. Melatonin protects against cardiac toxicity of doxorubicin in rat. J Pineal Res. 2001;31(4):301\u20137.","journal-title":"J Pineal Res"},{"key":"2472_CR53","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.colsurfb.2016.04.042","volume":"145","author":"M Sabzichi","year":"2016","unstructured":"Sabzichi M, Samadi N, Mohammadian J, Hamishehkar H, Akbarzadeh M, Molavi O. Sustained release of melatonin: a novel approach in elevating efficacy of tamoxifen in breast cancer treatment. Colloids Surf B. 2016;145:64\u201371.","journal-title":"Colloids Surf B"},{"issue":"12","key":"2472_CR54","doi-asserted-by":"publisher","first-page":"e82581","DOI":"10.1371\/journal.pone.0082581","volume":"8","author":"S Marepally","year":"2013","unstructured":"Marepally S, Boakye CH, Shah PP, Etukala JR, Vemuri A, Singh M. Design, synthesis of novel lipids as chemical permeation enhancers and development of nanoparticle system for transdermal drug delivery. PLoS ONE. 2013;8(12):e82581.","journal-title":"PLoS ONE"},{"issue":"1","key":"2472_CR55","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","volume":"65","author":"TM Allen","year":"2013","unstructured":"Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36\u201348.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"2472_CR56","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.tips.2009.08.004","volume":"30","author":"Y Malam","year":"2009","unstructured":"Malam Y, Loizidou M, Seifalian AM. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci. 2009;30(11):592\u20139.","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"2472_CR57","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/02652048.2017.1376001","volume":"34","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Ou C, Ye S, Song X, Luo S. Construction of nanoscale liposomes loaded with melatonin via supercritical fluid technology. J Microencapsul. 2017;34(7):687\u201398.","journal-title":"J Microencapsul"},{"key":"2472_CR58","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jconrel.2018.10.001","volume":"289","author":"SG Darband","year":"2018","unstructured":"Darband SG, Mirza-Aghazadeh-Attari M, Kaviani M, Mihanfar A, Sadighparvar S, Yousefi B, et al. Exosomes: natural nanoparticles as bio shuttles for RNAi delivery. J Control Rel. 2018;289:158.","journal-title":"J Control Rel"},{"issue":"2","key":"2472_CR59","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ejpb.2007.03.007","volume":"67","author":"V Dubey","year":"2007","unstructured":"Dubey V, Mishra D, Jain N. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm. 2007;67(2):398\u2013405.","journal-title":"Eur J Pharm Biopharm"},{"issue":"18","key":"2472_CR60","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1016\/j.biomaterials.2006.01.060","volume":"27","author":"V Dubey","year":"2006","unstructured":"Dubey V, Mishra D, Asthana A, Jain NK. Transdermal delivery of a pineal hormone: melatonin via elastic liposomes. Biomaterials. 2006;27(18):3491\u20136.","journal-title":"Biomaterials"},{"key":"2472_CR61","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.2147\/IJN.S124119","volume":"12","author":"S Sana","year":"2017","unstructured":"Sana S, Ghosh S, Das N, Sarkar S, Mandal AK. Vesicular melatonin efficiently downregulates sodium fluoride-induced rat hepato-and broncho-TNF-\u03b1, TGF-\u03b2 expressions, and associated oxidative injury: a comparative study of liposomal and nanoencapsulated forms. Int J Nanomed. 2017;12:4059.","journal-title":"Int J Nanomed"},{"key":"2472_CR62","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2147\/OPTH.S44708","volume":"8","author":"K Inoue","year":"2014","unstructured":"Inoue K. Managing adverse effects of glaucoma medications. Clin Ophthalmol (Auckland, NZ). 2014;8:903.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"10","key":"2472_CR63","doi-asserted-by":"publisher","first-page":"e110344","DOI":"10.1371\/journal.pone.0110344","volume":"9","author":"D Quinteros","year":"2014","unstructured":"Quinteros D, Vicario-de-la-Torre M, Andr\u00e9s-Guerrero V, Palma S, Allemandi D, Herrero-Vanrell R, et al. Hybrid formulations of liposomes and bioadhesive polymers improve the hypotensive effect of the melatonin analogue 5-MCA-NAT in rabbit eyes. PLoS ONE. 2014;9(10):e110344.","journal-title":"PLoS ONE"},{"issue":"2\u20134","key":"2472_CR64","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0009-3084(87)90071-5","volume":"45","author":"K Yagi","year":"1987","unstructured":"Yagi K. Lipid peroxides and human diseases. Chem Phys Lipid. 1987;45(2\u20134):337\u201351.","journal-title":"Chem Phys Lipid"},{"issue":"1","key":"2472_CR65","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3109\/02652048.2015.1115901","volume":"33","author":"D\u00c7 Alt\u0131ndal","year":"2016","unstructured":"Alt\u0131ndal D\u00c7, G\u00fcm\u00fc\u015fderelio\u011flu M. Melatonin releasing PLGA micro\/nanoparticles and their effect on osteosarcoma cells. J Microencapsul. 2016;33(1):53\u201363.","journal-title":"J Microencapsul"},{"issue":"4","key":"2472_CR66","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2174\/1567201814666170719112535","volume":"15","author":"LG Martins","year":"2018","unstructured":"Martins LG, Mainardes RM. PLGA nanoparticles and polysorbate-80-coated PLGA nanoparticles increase the in vitro antioxidant activity of melatonin. Curr Drug Deliv. 2018;15(4):554\u201363.","journal-title":"Curr Drug Deliv"},{"issue":"2","key":"2472_CR67","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijpharm.2012.10.014","volume":"440","author":"T Musumeci","year":"2013","unstructured":"Musumeci T, Bucolo C, Carbone C, Pignatello R, Drago F, Puglisi G. Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits. Int J Pharm. 2013;440(2):135\u201340.","journal-title":"Int J Pharm"},{"issue":"21","key":"2472_CR68","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1007\/s00018-017-2618-6","volume":"74","author":"Z Ma","year":"2017","unstructured":"Ma Z, Xin Z, Di W, Yan X, Li X, Reiter RJ, et al. Melatonin and mitochondrial function during ischemia\/reperfusion injury. Cell Mol Life Sci. 2017;74(21):3989\u201398.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2472_CR69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bjid.2016.11.004","volume":"21","author":"YPA de Oliveira","year":"2017","unstructured":"de Oliveira YPA, Pontes-de-Carvalho LC, Couto RD, Noronha-Dutra AA. Oxidative stress in sepsis. Possible production of free radicals through an erythrocyte-mediated positive feedback mechanism. Brazil J Infect Dis. 2017;21(1):19\u201326.","journal-title":"Brazil J Infect Dis."},{"key":"2472_CR70","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.biomaterials.2017.08.008","volume":"144","author":"G Chen","year":"2017","unstructured":"Chen G, Deng H, Song X, Lu M, Zhao L, Xia S, et al. Reactive oxygen species-responsive polymeric nanoparticles for alleviating sepsis-induced acute liver injury in mice. Biomaterials. 2017;144:30\u201341.","journal-title":"Biomaterials"},{"issue":"01","key":"2472_CR71","first-page":"13","volume":"67","author":"M Majidinia","year":"2017","unstructured":"Majidinia M, Alizadeh E, Yousefi B, Akbarzadeh M, Mihanfar A, Rahmati-Yamchi M, et al. Co-inhibition of notch and nf-\u03bab signaling pathway decreases proliferation through downregulating i\u03bab-\u03b1 and hes-1 expression in human ovarian cancer OVCAR-3 cells. Drug research. 2017;67(01):13\u20139.","journal-title":"Drug research"},{"issue":"1\u20132","key":"2472_CR72","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijpharm.2009.10.018","volume":"385","author":"C Mora-Huertas","year":"2010","unstructured":"Mora-Huertas C, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm. 2010;385(1\u20132):113\u201342.","journal-title":"Int J Pharm"},{"key":"2472_CR73","first-page":"197","volume-title":"Nanomedicine in cancer","author":"CP Reis","year":"2017","unstructured":"Reis CP, Neufeld RJ, Veiga F. Preparation of drug-loaded polymeric nanoparticles. In: Nanomedicine in cancer. Stanford: Pan Stanford; 2017. p. 197\u2013240."},{"issue":"2","key":"2472_CR74","first-page":"71","volume":"2","author":"P Kothamasu","year":"2012","unstructured":"Kothamasu P, Kanumur H, Ravur N, Maddu C, Parasuramrajam R, Thangavel S. Nanocapsules: the weapons for novel drug delivery systems. Bioimpacts. 2012;2(2):71.","journal-title":"Bioimpacts"},{"issue":"6","key":"2472_CR75","doi-asserted-by":"publisher","first-page":"e0157561","DOI":"10.1371\/journal.pone.0157561","volume":"11","author":"ER Komninou","year":"2016","unstructured":"Komninou ER, Remi\u00e3o MH, Lucas CG, Domingues WB, Basso AC, Jornada DS, et al. Effects of two types of melatonin-loaded nanocapsules with distinct supramolecular structures: polymeric (NC) and lipid-core nanocapsules (LNC) on bovine embryo culture model. PLoS ONE. 2016;11(6):e0157561.","journal-title":"PLoS ONE"},{"issue":"1","key":"2472_CR76","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/1556-276X-7-251","volume":"7","author":"CR Hoffmeister","year":"2012","unstructured":"Hoffmeister CR, Durli TL, Schaffazick SR, Raffin RP, Bender EA, Beck RC, et al. Hydrogels containing redispersible spray-dried melatonin-loaded nanocapsules: a formulation for transdermal-controlled delivery. Nanoscale Res Lett. 2012;7(1):251.","journal-title":"Nanoscale Res Lett"},{"issue":"1","key":"2472_CR77","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejpb.2007.11.010","volume":"69","author":"SR Schaffazick","year":"2008","unstructured":"Schaffazick SR, Siqueira IR, Badejo AS, Jornada DS, Pohlmann AR, Netto CA, et al. Incorporation in polymeric nanocapsules improves the antioxidant effect of melatonin against lipid peroxidation in mice brain and liver. Eur J Pharm Biopharm. 2008;69(1):64\u201371.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"2472_CR78","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1517\/14712598.4.1.35","volume":"4","author":"NK Varde","year":"2004","unstructured":"Varde NK, Pack DW. Microspheres for controlled release drug delivery. Expert Opin Biol Ther. 2004;4(1):35\u201351.","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"2472_CR79","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3109\/02652049809008260","volume":"15","author":"B-J Lee","year":"1998","unstructured":"Lee B-J, Choe J, Kim C-K. Preparation and characterization of melatonin-loaded stearyl alcohol microspheres. J Microencapsul. 1998;15(6):775\u201387.","journal-title":"J Microencapsul"},{"issue":"1\u20132","key":"2472_CR80","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijpharm.2003.11.028","volume":"272","author":"S Mao","year":"2004","unstructured":"Mao S, Chen J, Wei Z, Liu H, Bi D. Intranasal administration of melatonin starch microspheres. Int J Pharm. 2004;272(1\u20132):37\u201343.","journal-title":"Int J Pharm"},{"issue":"4","key":"2472_CR81","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1208\/s12249-012-9829-9","volume":"13","author":"PL Mamani","year":"2012","unstructured":"Mamani PL, Ruiz-Caro R, Veiga MD. Matrix tablets: the effect of hydroxypropyl methylcellulose\/anhydrous dibasic calcium phosphate ratio on the release rate of a water-soluble drug through the gastrointestinal tract I. In Vitro tests. AAPS PharmSciTech. 2012;13(4):1073\u201383.","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"2472_CR82","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1081\/DDC-100102199","volume":"25","author":"B-J Lee","year":"1999","unstructured":"Lee B-J, Ryu S-G, Cui J-H. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin. Drug Dev Ind Pharm. 1999;25(4):493\u2013501.","journal-title":"Drug Dev Ind Pharm"},{"key":"2472_CR83","first-page":"3421","volume":"10","author":"RA Meyer","year":"2015","unstructured":"Meyer RA, Green JJ. Biodegradable polymer iron oxide nanocomposites: the future of biocompatible magnetism. Future Med. 2015;10:3421.","journal-title":"Future Med"},{"key":"2472_CR84","doi-asserted-by":"publisher","first-page":"7351","DOI":"10.2147\/IJN.S148520","volume":"12","author":"W Xie","year":"2017","unstructured":"Xie W, Gao Q, Wang D, Wang W, Yuan J, Guo Z, et al. Melatonin potentiates \u201cinside-out\u201d nano-thermotherapy in human breast cancer cells: a potential cancer target multimodality treatment based on melatonin-loaded nanocomposite particles. Int J Nanomed. 2017;12:7351.","journal-title":"Int J Nanomed"},{"issue":"1","key":"2472_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jfb9010001","volume":"9","author":"D Massella","year":"2018","unstructured":"Massella D, Leone F, Peila R, Barresi A, Ferri A. Functionalization of cotton fabrics with polycaprolactone nanoparticles for transdermal release of melatonin. J Funct Biomater. 2018;9(1):1.","journal-title":"J Funct Biomater"},{"issue":"19","key":"2472_CR86","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.2174\/092986710791233689","volume":"17","author":"E S\u00e1nchez-Barcel\u00f3","year":"2010","unstructured":"S\u00e1nchez-Barcel\u00f3 E, Mediavilla M, Tan D, Reiter R. Clinical uses of melatonin: evaluation of human trials. Curr Med Chem. 2010;17(19):2070\u201395.","journal-title":"Curr Med Chem"},{"key":"2472_CR87","first-page":"CD001520","volume":"2","author":"A Herxheimer","year":"2002","unstructured":"Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev. 2002;2:CD001520.","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"2472_CR88","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3109\/07420529808993201","volume":"15","author":"A Suhner","year":"1998","unstructured":"Suhner A, Schlagenhauf P, Johnson R, Tschopp A, Steffen R. Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag. Chronobiol Int. 1998;15(6):655\u201366.","journal-title":"Chronobiol Int"},{"issue":"6","key":"2472_CR89","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1258\/ebm.2012.011425","volume":"237","author":"G Li Volti","year":"2012","unstructured":"Li Volti G, Musumeci T, Pignatello R, Murabito P, Barbagallo I, Carbone C, et al. Antioxidant potential of different melatonin-loaded nanomedicines in an experimental model of sepsis. Exp Biol Med. 2012;237(6):670\u20137.","journal-title":"Exp Biol Med"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-022-02472-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-022-02472-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-022-02472-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T23:45:28Z","timestamp":1666395928000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-022-02472-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2472"],"URL":"https:\/\/doi.org\/10.1186\/s12935-022-02472-7","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,29]]},"assertion":[{"value":"2 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}